Delivery Order SPE2DB22D9353-SPE2DB26FX1JS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,379.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, was awarded without set-aside designation. DMS Pharmaceutical Group is registered in the System for Award Management and has maintained...
- The Defense Logistics Agency awarded a $1,547.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This delivery order, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, carries no set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $37,137.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on August 26, 2025, carries an ultimate completion date of September 17, 2025, with performance occurring at the vendor's Park Ridge facility. The award was made without a set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, valued at $1,547.40 with an ultimate completion date of September 10, 2025, was issued without set-aside designation. DMS Pharmaceutical Group competes effectively in federal procurement leveraging its small business status and established...
- The Defense Logistics Agency awarded a $37.5K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL syringes. This delivery order, which is expected to be completed by September 11, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge, Illinois location and will deliver this biologic medication to...
- The Defense Logistics Agency awarded a delivery order valued at $23,211.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 26, 2025, with an ultimate completion date of October 20, 2025, was awarded without a set-aside designation. The order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a $1,547.40 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml syringes. The contract is firm fixed-price with an ultimate completion date of September 18, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/ml syringes, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which provides a wide range of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,547.42 to DMS Pharmaceutical Group Inc. on September 13, 2025, for the supply of Xolair 150mg vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order carries a firm fixed-price contract type with an ultimate completion date of September 29, 2025, and will be fulfilled at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $38,685 by the Defense Logistics Agency on September 25, 2025, for the supply of Xolair 150 mg/ml syringes. The contract is a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of October 17, 2025. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB26FX1JSDelivery Order
The Defense Logistics Agency awarded a $55,706.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/mL syringes. The contract, awarded on October 8, 2025, with an ultimate completion date of October 30, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform work at its Park Ridge facility and deliver this pharmaceutical product to support Defense Department healthcare operations. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and effective through November 2026. The IDC enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support military health facilities worldwide. DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure recurring contracts for critical medical supplies and medications distributed to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.7k | 10/8/25 |